Mar 26 |
Syra Health Corp. Class A Common Stock (NASDAQ:SYRA) Q4 2023 Earnings Call Transcript
|
Mar 25 |
Syra Health Corp. (SYRA) Q4 2023 Earnings Call Transcript
|
Mar 25 |
Syra Health reports mixed FY results; initiates FY24 outlook
|
Mar 25 |
Syra Health Announces Fourth-Quarter and Full-Year 2023 Financial Results. Projects 2024 Revenue Growth of 64% to 100%.
|
Mar 25 |
Earnings Scheduled For March 25, 2024
|
Mar 21 |
Syra Health to Deliver Substance Use Disorder and Overdose Prevention Training in Kansas
|
Mar 12 |
US Health Agency Reviews Novo Nordisk's Wegovy For Potential Use In Treating Heart Disease Patients With Obesity
|
Mar 8 |
(SYRA) - Analyzing Syra Health's Short Interest
|
Mar 6 |
Syra Health to Present at the Life Science Investor Forum March 7th
|
Mar 5 |
Life Science Virtual Investor Forum Agenda Announced for March 7th, 2024
|